JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB179815

Anti-Rab9 antibody [EPR13272] - Late Endosome Marker

4

(4 Reviews)

|

(13 Publications)

Rabbit Recombinant Monoclonal Rab9 antibody. Late Endosome marker. Suitable for WB, ICC/IF and reacts with Mouse, Rat, Human samples. Cited in 13 publications.

View Alternative Names

RAB9, RAB9A, Ras-related protein Rab-9A

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

Immunofluorescent staining of HepG2 cells labeling Rab9 with unpurified ab179815 at 1/50 dilution (red). DAPI nuclear staining (blue).

Immunocytochemistry/ Immunofluorescence - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

Immunofluorescence staining of HepG2 cells with purified ab179815 at a working dilution of 1/250, counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077), used at a dilution of 1/1000. ab7291, a mouse anti-tubulin antibody (1/1000), was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse, 1/1000), shown in the top right hand panel. The cells were fixed in 100% methanol and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1, purified ab179815 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2, ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • WB

Supplier Data

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

All lanes:

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (ab179815) at 1/1000 dilution

Lane 1:

K562 cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

293T cell lysate at 10 µg

Lane 4:

HepG2 cell lysate at 10 µg

Predicted band size: 23 kDa

false

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • WB

Lab

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (ab179815) at 1/2000 dilution

Lane 1:

K562 cell lysate at 20 µg

Lane 2:

HeLa cell lysate at 20 µg

Lane 3:

HepG2 cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • WB

Lab

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

Lanes 1-4 : Merged signal (red and green). Green - ab179815 observed at 25 kDa. Red - loading control ab8245 observed at 36 kDa.

ab179815 Anti-Rab9 antibody [EPR13272] was shown to specifically react with Rab9 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265693 (knockout cell lysate ab257625) was used. Wild-type and Rab9 knockout samples were subjected to SDS-PAGE. ab179815 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (ab179815) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

RAB9A knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human RAB9A (Rab9) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-rab9a-rab9-knockout-hela-cell-line-ab265693'>ab265693</a>)

Lane 3:

MCF7 cell lysate at 20 µg

Lane 4:

MDA-MB-231 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 23 kDa

Observed band size: 25 kDa

false

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • WB

Lab

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (ab179815) at 1/2000 dilution

All lanes:

rat kidney at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)
  • WB

Lab

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (AB179815)

Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Rab9 antibody [EPR13272] - Late Endosome Marker (ab179815) at 1/2000 dilution

All lanes:

mouse spleen at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

  • Carrier free

    Anti-Rab9 antibody [EPR13272] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13272

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p><strong>For unpurified, use 1/50 - 1/100.</strong></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Rab9 also known as Ras-related protein Rab-9A is a small GTPase and part of the Rab family with a mass of around 23 kDa. This protein mainly resides in the trans-Golgi network and late endosomes. Rab9 plays an important role in the transport of mannose 6-phosphate receptors between late endosomes and the Golgi apparatus facilitating cargo sorting and vesicular trafficking in cells.
Biological function summary

Rab9 coordinates several intracellular trafficking processes aiding in the regulation of membrane identity. It associates with other effectors such as tail-interacting protein (TIP47) to form complexes on the endosomal surface. These complexes help in vesicular transport ensuring efficient recycling of receptors. Rab9 impacts endosome maturation and transport making it an essential endosome marker.

Pathways

Rab9 influences and is involved in the regulation of the endocytic and secretory pathways. It interacts with proteins like Rab7 another GTPase to manage late endosome and lysosome transport. These interactions underline Rab9's functionalities in intracellular trafficking and recycling processes relying on cooperative interactions with other Rabs and their effectors.

Rab9 plays a role in conditions like Niemann-Pick disease type C and some neurological disorders. Disruption in Rab9 function may affect lipid trafficking and lead to accumulation of cholesterol in late endosomes. This links Rab9 indirectly to proteins such as NPC1 which is known to be implicated in cholesterol homeostasis. Understanding Rab9's involvement can help inform therapeutic strategies targeting these pathways in related diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in the transport of proteins between the endosomes and the trans Golgi network. Involved in the recruitment of SGSM2 to melanosomes and is required for the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes.
See full target information RAB9A

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Cell proliferation 57:e13595 PubMed38185785

2024

Prickle1-driven basement membrane deposition of the iPSC-derived embryoid bodies is separable from the establishment of apicobasal polarity.

Applications

Unspecified application

Species

Unspecified reactive species

Dianlei Guo,Sikai Liu,Jiao Zhang,Xinyu Gu,Lei Shi,Yingchun Su,Shujuan Xu,Rong Ju,Yanhong Wei,Chunqiao Liu

Biomolecules 13: PubMed36979451

2023

Dysregulation of AMPA Receptor Trafficking and Intracellular Vesicular Sorting in the Prefrontal Cortex of Dopamine Transporter Knock-Out Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Giorgia Targa,Francesca Mottarlini,Beatrice Rizzi,Damiana Leo,Lucia Caffino,Fabio Fumagalli

Biology open 11: PubMed35929543

2022

The uncoating of EV71 in mature late endosomes requires CD-M6PR.

Applications

Unspecified application

Species

Unspecified reactive species

Seii Ohka,Soon Hao Tan,Eri Ishiyama,Katsutoshi Ogasawara,Tomohito Hanasaka,Kinji Ishida,Kyoji Hagiwara,Chia-Chyi Liu,Pele Choi-Sing Chong,Ken-Ichi Hanaki,Giampietro Schiavo

Polymers 13: PubMed33805425

2021

Hypomyelinating Leukodystrophy 15 (HLD15)-Associated Mutation of EPRS1 Leads to Its Polymeric Aggregation in Rab7-Positive Vesicle Structures, Inhibiting Oligodendroglial Cell Morphological Differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Sui Sawaguchi,Mizuki Goto,Yukino Kato,Marina Tanaka,Kenji Tago,Hiroaki Oizumi,Katsuya Ohbuchi,Kazushige Mizoguchi,Yuki Miyamoto,Junji Yamauchi

Medicines (Basel, Switzerland) 8: PubMed33535532

2021

The Infantile Leukoencephalopathy-Associated Mutation of C11ORF73/HIKESHI Proteins Generates de novo Interactive Activity with Filamin A, Inhibiting Oligodendroglial Cell Morphological Differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Kohei Hattori,Kenji Tago,Shiori Memezawa,Arisa Ochiai,Sui Sawaguchi,Yukino Kato,Takanari Sato,Kazuma Tomizuka,Hiroaki Ooizumi,Katsuya Ohbuchi,Kazushige Mizoguchi,Yuki Miyamoto,Junji Yamauchi

Proceedings of the National Academy of Sciences of the United States of America 116:10473-10481 PubMed31068463

2019

Rational vaccinology with spherical nucleic acids.

Applications

Unspecified application

Species

Unspecified reactive species

Shuya Wang,Lei Qin,Gokay Yamankurt,Kacper Skakuj,Ziyin Huang,Peng-Cheng Chen,Donye Dominguez,Andrew Lee,Bin Zhang,Chad A Mirkin

OncoTargets and therapy 12:1815-1824 PubMed30881034

2019

The overexpression of Rab9 promotes tumor progression regulated by XBP1 in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yansong Liu,Xin Wang,Zhonghua Zhang,Bin Xiao,Baoming An,Jun Zhang

Theranostics 8:3474-3489 PubMed30026860

2018

Drug-delivering-drug platform-mediated potent protein therapeutics a non-endo-lysosomal route.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofei Xin,Chao Teng,Xiaoqing Du,Yaiqi Lv,Qingqing Xiao,Yubing Wu,Wei He,Lifang Yin

Scientific reports 7:6454 PubMed28743942

2017

Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Sang-Woo Kim,Yeon Kyung Lee,Sang-Hyun Kim,Jun-Young Park,Dong Un Lee,Jungil Choi,Jeong Hee Hong,Sanghyo Kim,Dongwoo Khang

Chemical science 8:6829-6835 PubMed29147508

2017

Chiral nanoprobes for targeting and long-term imaging of the Golgi apparatus.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Sheng Li,Peng Fei Gao,Hong Zhi Zhang,Lin Ling Zheng,Chun Mei Li,Jian Wang,Yuan Fang Li,Feng Liu,Na Li,Cheng Zhi Huang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com